Medical Press Release - Page 10 of 12 - Medika Life : Keeping you informed

Many Americans are confused about the basics of health insurance, despite widespread attention on health care during this year's global pandemic and election season.

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Medika Life - June 8, 2025

Researchers at the Icahn School of Medicine at Mount Sinai have developed a machine learning tool that can help doctors manage blood sugar levels...

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

FDA grants yet another EUA for RNA Extraction-Free Covid-19 Assay

Medika Life - September 8, 2020

A SARS-CoV-2 diagnostic test which eliminates the costly and time-consuming step of RNA extraction. As opposed to most other molecular assays that rely on RNA extraction and qRT-PCR

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

FINN Partners Brings Aboard the Pharmacy Podcast Network

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

South University Announces New MSPA Program at West Palm Beach Campus

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

Survey Finds Widespread Confusion Around US Health Insurance

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

FDA grants yet another EUA for RNA Extraction-Free Covid-19 Assay

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories